Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2005
  • Online publication date: August 2009

17 - Heat Shock Protein Fusions: A Platform for the Induction of Antigen-Specific Immunity

Summary

Introduction

The unusual immunogenicity of heat shock proteins (also known as stress proteins) was discovered in studies of the immune response to microbial infection, in which a large proportion of the humoral and cellular immune response to diverse microbial pathogens was found to be specific for pathogen-derived heat shock protein [1]. These studies demonstrated that immune recognition of pathogen-derived heat shock proteins occurs in natural and experimental settings in animals and man. This is discussed in detail in Chapter 16. Immune responses elicited to mycobacterial heat shock proteins have been particularly well studied. In man, recognition of mycobacterial heat shock protein by CD4+ T cells occurs in the context of numerous human leukocyte antigen (HLA) alleles, and epitopes have been identified that are presented by multiple HLA molecules [2]. The promiscuous recognition of mycobacterial heat shock proteins supports their utility as ‘universal’ immunogens for the genetically diverse human population. The immunogenic properties of microbial heat shock proteins have accordingly led to their application in a variety of immunisation formats as prophylactic and therapeutic agents in models of infectious disease and cancer [3]. In these studies, heat shock proteins have been delivered as subunit vaccines, carrier proteins in chemical conjugates, recombinant fusion proteins and DNA expression vectors for induction of humoral and cellular immunity.

To explain the disproportionate focus of the immune response on a small subset of pathogen antigens, heat shock proteins were proposed to act as ‘red flags’ – alerting the immune system to the presence of a foreign invader [4].

References
Suzue K and Young R A. Heat shock proteins as immunological carriers and vaccines. In Fiege, U. (Ed.) Stress-Inducible Cellular Responses. Birkhauser Verlag, Basel 1996, pp 451–465
Mustafa, A S.HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Human Immunol 2000, 61: 166–171
Mizzen, L.Immune responses to stress proteins: applications to infectious disease and cancer. Biotherapy 1998, 10: 173–189
Murray, P and Young, R A.Stress and immunological recognition in host-pathogen interactions. J Bacteriol 1992, 174: 4193–4196
Garbe, T R.Heat shock proteins and infection: interactions of pathogen and host. Experientia 1992, 48: 635–639
Gallucci, S and Matzinger, P.Danger signals: SOS to the immune system. Cur Opin Immunol 2001, 13: 114–119
Asea, A, Kraeft, S-K, Kurt-Jones, E A, Stevenson, M A, Chen, L B, Finberg, R W, Koo, G C and Calderwood, S K.Hsp70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000, 6: 435–442
Kol, A, Lichtman, A H, Finberg, R W, Libby, P and Kurt-Jones, E A.Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000, 164: 13–17
Ohashi, K, Burkart, V, Flohé, S and Kolb, H.Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol 2000, 164: 558–561
Basu, S, Binder, R J, Ramalingam, T and Srivastava, P K.CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity 2001, 14: 303–313
Vabulas, R M, Ahmad-Nejad, P, da Costa, C, Miethke, T, Kirschning, C J, Hacker, H and Wagner, H.Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001, 276: 31332–31339
Wang, Y, Kelly, C G, Karttunen, T, Whittall, T, Lehner, P J, Duncan, L, MacAry, P, Younson, J S, Singh, M, Oehlmann, W, Cheng, G, Bergmeier, L and Lehner, T.CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001, 15: 971–983
Becker, T, Hartl, F U and Wieland, F.CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 2002, 158: 1277–1285
Delneste, Y, Magistrelli, G, Gauchat, J, Haeuw, J, Aubry, J, Nakamura, K, Kawakami-Honda, N, Goetsch, L, Sawamura, T, Bonnefoy, J and Jeannin, P.Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002, 17: 353–362
Gross, C, Hansch, D, Gastpar, R and Multhoff, G.Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem 2003, 384: 267–279
Krieger, M.The other side of scavenger receptors: pattern recognition for host defense. Cur Opin Lipidol 1997, 8: 275–280
Janeway, C A J and Medzhitov, R.Innate immune recognition. Ann Rev Immunol 2002, 20: 197–216
Multhoff, G, Mizzen, L, Winchester, C C, Milner, C M, Wenk, S, Eissner, G, Kampinga, H H, Laumbacher, B and Johnson, J.Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol 1999, 27: 1627–1636
Yang, Y and Wilson, J M.CD40 ligand-dependent T cell activation: requirement of B7-CD28 signalling through CD40. Science 1996, 273: 1862–1864
Kuppner, M C, Gastpar, R, Gelwer, S, Nossner, E, Ochmann, O, Scharner, A and Issels, R D.The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol 2001, 31: 1602–1609
Bethke, K, Staib, F, Distler, M, Schmitt, U, Jonuleit, H, Enk, A H, Galle, P R and Heike, M.Different efficiency of heat shock proteins to activate human monocytes and dendritic cells: Superiority of HSP60. J Immunol 2002, 169: 6141–6148
Arnold, D, Faath, S, Rammensee, H-G and Schild, H.Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995, 182: 885–889
Suto, R and Srivastava, P K.A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995, 269: 1585–1588
Suzue, K and Young, R A.Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 1996, 156: 873–879
Rico, A I, Angel, S O, Alonso, C and Requena, J M.Immunostimulatory properties of the Leishmania infantum heat shock proteins hsp70 and hsp83. Mol Immunol 1999, 36: 1131–1139
Rico, A I, Del Real, G, Soto, M, Quijada, L, Martinez-A, C, Alonso, C and Requena, J M.Characterization of the immunostimulatory properties of Leishmania infantum Hsp70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun 1998, 66: 347–352
Echeverria, P, Dran, G, Pereda, G, Rico, A I, Requena, J M, Alonso, C, Guarnera, E and Angel, S O.Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination. Immunol Lett 2001, 76: 107–110
Bonorino, C, Nardi, N B, Zhang, X and Wysocki, L J.Characteristics of the strong antibody response to mycobacterial hsp70: a primary, T cell-dependent IgG response with no evidence of natural priming or γδ T cell involvement. J Immunol 1998, 161: 5210–5216
Suzue, K, Zhou, X, Eisen, H N and Young, R A.Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Nat Acad Sci USA 1997, 94: 13146–13151
Maranon, C, Thomas, M C, Planelles, L and Lopez, M C.The immunization of A2/Kb transgenic mice with the kmp11-hsp70 fusion protein induces CTL response against human cells expressing the T. cruzi kmp11 antigen: identification of A2-restricted epitopes. Mol Immunol 2001, 38: 279–287
Anthony, L S D, Wu, H, Sweet, H, Turnnir, C, Boux, L and Mizzen, L A.Priming of CD8+ CTL effector cells in mice by immunization with a stress protein – influenza virus nucleoprotein fusion molecule. Vaccine 1999, 17: 373–383
Chu, N R, Wu, H B, Boux, L J, Siegel, M I and Mizzen, L A.Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7. Clin Exp Immunol 2000, 121: 216–225
Cho, B K, Palliser, D, Guillen, E, Wisniewski, J, Young, R A, Chen, J and Eisen, H N.A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 2000, 12: 263–272
Huang, Q, Richmond, J F, Suzue, K, Eisen, H N and Young, R A.In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4+ T cell independent. J Exp Med 2000, 191: 403–408
Udono, H, Yamano, T, Kawabata, Y, Ueda, M and Yui, K.Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 2001, 13: 1233–1242
Harmala, L A E, Ingulli, E G, Curtsinger, J M, Lucido, M M, Schmidt, C S, Weigel, B J, Blazar, B R, Mescher, M F and Pennell, C A.The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo. J Immunol 2002, 169: 5622–5629
Rahemtulla, A, Fung-Leung, W P, Schillham, M W, Kundig, T M, Sambhara, S R, Narendran, A, Arabian, A, Wakeham, A, Paige, C J, Zinkernagel, R M, Miller, R G and Mak, T W.Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991, 353: 180–184
Ridge, J P, Di Rosa, F and Matzinger, P.A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998, 393: 474–478
Gurunathan, S, Klinman, D M and Seder, R A.DNA vaccines: immunology, application, and optimization. Ann Rev Immunol 2000, 18: 927–974
Chen, C-H, Wang, T-L, Hung, C-F, Yang, Y, Young, R A, Pardoll, D M and Wu, T-C.Enhancement of DNA vaccine potency by linkage of antigen gene to an hsp70 gene. Cancer Res 2000, 60: 1035–1042
Cheng, W F, Hung, C F, Lin, K Y, Juang, J, He, L, Lin, C T and Wu, T-C.CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Gene Therapy 2003, 10: 1311–1320
Liu, D-W, Tsao, Y-P, Kung, J T, Ding, Y-A, Sytwu, H-K, Xiao, X and Chen, S-L.Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000, 74: 2888–2894
Cheng, W-F, Hung, C-F, Chai, C-Y, Hsu, K-F, He, L, Rice, C M, Ling, M and Wu, T-C.Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J Immunol 2001, 166: 6218–6226
Hsu, K-F, Hung, C-F, Cheng, W-F, He, L, Slater, L A, Ling, M and Wu, T-C.Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Therapy 2001, 8: 376–383
Plannelles, L, Thomas, M C, Alonso, C and Lopez, M C.DNA immunization with Trypanosoma cruzi Hsp70 fused to the kmp11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 2001, 69: 6558–6563
Cheng, W F, Hung, C F, Chai, C Y, Hsu, K F, He, L, Ling, M and Wu, T C.Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001, 108: 669–678
Wassenberg, J J, Dezfulian, C and Nicchitta, C V.Receptor mediated and fluid phase pathways for internalization of the ER hsp90 chaperone grp94 in murine macrophages. J Cell Sci 1999, 112: 2167–2175
Castellino, F, Boucher, P E, Eichelberg, K, Mayhew, M, Rothman, J E, Houghton, A N and Germain, R N.Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct pathways. J Exp Med 2000, 191: 1957–1964
Koutsky, L.Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102 (suppl 5A): 3–8
Gissmann, L, Osen, W, Muller, M and Jochmus, I.Therapeutic vaccines for human papillomaviruses. Intervirology 2001, 44: 167–175
Richart, R M, Masood, S, Syrjanen, K J, Vassilakos, P, Kaufman, R H, Meisels, A, Olszewski, W T, Sakamoto, A, Stoler, M H, Vooijs, G P and Wilbur, D C.Human papillomavirus. IAC task force summary. Acta Cytologica 1998, 42: 50–58
Goldstone, S E, Palefsky, J M, Winnett, M T and Neefe, J R.Activity of HspE7, a novel immunotherapy, in patients with anogenital warts. Dis Colon Rectum 2002, 45: 502–507
Srivastava, P K, Udono, H, Blachere, N E and Li, Z.Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994, 39: 93–98
Raychaudhuri, S and Morrow, W J W.Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited. Immunol Today 1993, 14: 344–348
Gupta, R K and Siber, G R.Adjuvants for human vaccines – current status, problems and future prospects. Vaccine 1995, 13: 1263–1276